American Society of Clinical Psychopharmacology

09/17/2026

Treatment resistance remains one of the most challenging areas in psychiatry. In the latest episode of Psychopharm Today, Maurizio Fava, MD, joins host Michael E. Henry, MD, to discuss treatment resistance, placebo response, and where the field may be headed next. Listen to the full conversation now. https://bit.ly/4hlnhu4

09/15/2026

Submissions are now open for the 2027 ASCP Annual Meeting in Chicago. Share your research, propose a panel or workshop, apply for a New Investigator Award, or submit a Pharmaceutical Pipeline Presentation.

Review the submission opportunities, guidelines, and deadlines and submit your work today.
🔗https://bit.ly/42Udfsq

09/09/2026

The deadline to volunteer is almost here.

Join the Review Subcommittee for the 2027 ASCP Annual Meeting and help evaluate submissions as part of the selection process.

Sign up by October 9, 2026.

Volunteer here: https://bit.ly/4xYefJg

09/07/2026

Wishing everyone a restful and well-deserved Labor Day! Our office is closed today. We'll return tomorrow to keep doing the work we love. Thank you for your continued trust and partnership.

08/28/2026

🎙️ New episode of Psychopharm Today is out now!

Host Jenessa Johnston, PhD, is joined by James Murrough, MD, PhD, of the Icahn School of Medicine at Mount Sinai, and Hiroe Hu, DO, a clinical research fellow in the National Institute of Mental Health’s Experimental Therapeutics and Pathophysiology Branch, to explore the case for entactogenic therapeutics and their potential role in mental health care.

🎧 Tune in to hear their discussion on this emerging area of research.

08/26/2026

Help shape the 2027 ASCP Annual Meeting.
ASCP is seeking volunteers to serve on the Review Subcommittee and provide thoughtful feedback on Annual Meeting submissions.
Volunteer by October 9, 2026.
Learn more and sign up: https://bit.ly/4xYefJg

08/19/2026

Come check out our latest podcast episode of Psychopharm Today in collaboration with Psychiatric Times. In this episode, discover how novel entactogenic therapies may help the treatment of mood and anxiety disorders from experts Hiroe Hu, DO and James Murrough, MD, PhD.

Episode hosted by: Jenessa Johnston, PhD

https://www.psychiatrictimes.com/view/podcast-exploring-entactogens-with-hiroe-imai-hu-do-and-james-w-murrough-md-phd

08/10/2026

https://www.einpresswire.com/article/933089535/new-ascp-review-examines-antidepressant-discontinuation-symptoms-amid-growing-scientific-and-public-debate

A newly published review by members of the American Society of Clinical Psychopharmacology (ASCP) examines what current evidence shows and does not show about

07/22/2026

🎙️ New Episode of Psychopharm Today is Here!

Metabolic health is an essential part of psychiatric care, but are we doing enough to identify and address cardiometabolic risk?

In the latest episode of Psychopharm Today, host Jessica Gannon, MD, is joined by Benjamin I. Perry, PhD; Nicolette Stogios, PhD; and Katharine Liang, MD, PhD to discuss:
✔️ Why metabolic screening matters across psychiatric diagnoses
✔️ Tailored interventions for high-risk populations
✔️ The emerging PsyMetRiC risk calculator
✔️ How to communicate metabolic risk while supporting treatment adherence

🎧 Listen now wherever you get your podcasts.

07/15/2026

🎙️ Now Streaming: Psychopharm Today

Understanding su***de risk requires looking beyond diagnosis.
In this episode of Psychopharm Today, host Jenessa Johnston, PhD, is joined by Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD, to discuss the complexities of su***de prevention and why more targeted, su***de-specific research is essential.

Based on a panel from the 2026 ASCP Annual Meeting, the conversation explores:
✔️ Why su***de risk extends across psychiatric diagnoses
✔️ The importance of su***de-specific research
✔️ Personalized approaches to prevention and intervention
✔️ The value of meaningful clinician-patient conversations

🎧 Listen now.